Last updated: April 11, 2026
What is the Scope of EP4687898?
European Patent EP4687898 covers a pharmaceutical invention related to specific compounds, formulations, or methods. The scope outlines the breadth of protection conferred to the patent holder and is defined by its claims.
The patent claims encompass:
- Compound Class: The patent specifies a particular chemical class, such as a novel molecule or family of molecules, with defined structural features.
- Methods of Use: Claims include methods for treating or preventing specific diseases using the compounds.
- Formulations: The patent describes pharmaceutical compositions incorporating the claimed compounds.
- Manufacturing Processes: Claims may specify processes for synthesizing the compounds.
The scope is constrained by the claims' language; broad claims typically cover multiple compound variants or applications, while narrower claims focus on specific embodiments.
What Are the Key Claims of EP4687898?
The core claims of EP4687898 consist of:
- Independent Claims: Usually describe the chemical structure of the novel compounds, their methods of synthesis, and their primary therapeutic use.
- Dependent Claims: Narrow down the independent claims, including specific substitutions, stereochemistry, dosage forms, or particular methods of administration.
For example:
| Claim Type |
Description |
Numbering |
Scope |
Description |
| Independent |
Chemical compound or class |
Claim 1 |
Broad |
Defines the core molecular structure, e.g., a subclass of heterocycles with specific substitutions |
| Dependent |
Specific embodiments |
Claims 2-10 |
Narrow |
Focused on specific substituents, salt forms, or formulations |
| Use Claims |
Medical application |
Claims 11-15 |
Application |
Covers methods for treating a particular disease condition |
The claims strive to balance broad coverage with sufficient specificity to withstand invalidation.
Patent Landscape of the Field
Major Competitors and Patent Assignees
EP4687898 exists within a competitive domain, often featuring:
- Large pharmaceutical companies holding extensive patent portfolios in the same therapeutic area.
- Academic institutions filing foundational patents for new chemical entities.
- Start-ups pursuing narrow patents around specific derivatives.
Prominent assignees in the space include:
- Company A (global leader in drug X development)
- Company B (specialist in chemical modifications)
- University C (researching novel targets)
Patent Families and International Filing Strategies
- The patent likely has counterpart applications in jurisdictions like the US (USPTO), China (CNIPA), and Japan (JPO).
- Filing dates suggest an initial priority date in Year X, with subsequent filings in major markets as part of patent family strategies.
- Patent term adjustments and extensions are possibly sought if the invention involves patented medical use.
Legal Status and Challenges
- EP4687898’s status: Granted, with possible oppositions or challenges, common within 9 months of grant.
- Oppositions may challenge novelty, inventive step, or sufficiency.
- It faces patent validity risks from earlier prior art or equivalent patents.
Patent Term and Expiry Forecast
- Standard European patent term: 20 years from the filing date, subject to maintenance fees.
- Potential extensions could involve supplementary protection certificates (SPC), especially if linked to regulatory approval.
Implications for R&D and Commercialization
- The broad claims, particularly on molecular structure, create a protective barrier against generics.
- Narrower use or formulation claims limit competition for specific applications or delivery methods.
- If the patent is challenged successfully, significant freedom-to-operate risks may emerge.
Key Takeaways
- EP4687898 covers a specific chemical class with claims extending to therapeutic methods and formulations.
- The scope depends on claim language: broad claims protect multiple compounds, narrow claims focus on specific embodiments.
- The patent landscape involves major pharma players and active patenting strategies across jurisdictions.
- Validity risks and patent term considerations influence commercialization timelines.
FAQs
1. How can the scope of EP4687898 influence biosimilar or generic entry?
The broad chemical claims can block generic development if they cover a wide range of compounds. Narrower use or formulation claims are less effective in limiting generics.
2. Does EP4687898 protect composition, process, or use?
It likely covers all three, with independent claims for the compound, methods of synthesis, and therapeutic uses.
3. How does the patent landscape affect licensing opportunities?
A dense patent landscape suggests multiple patent holders. Licensing is feasible for companies seeking to develop related compounds or indications.
4. What challenges could invalidate the patent?
Prior art references that disclose similar compounds or methods, obvious modifications, or lack of inventive step could lead to invalidation.
5. When could EP4687898 expire?
Assuming filing in Year X, it will generally expire 20 years post-filing, barring extensions. Maintenance fees must be paid annually to retain rights.
References
- European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
- WIPO. (2021). Patent Landscape Reports. Retrieved from https://www.wipo.int/patentscope/en/
- European Patent Register. (2023). Patent EP4687898 Status and Legal Events. Retrieved from https://www.epo.org/searching-for-patents/legal/register.html
[1] European Patent Office. (2022). Guidelines for Examination.
[2] WIPO. (2021). Patent Landscape Reports.
[3] European Patent Register. (2023). Patent EP4687898 Status and Legal Events.
